When to consider adjuvant/neoadjuvant therapy for adult soft-tissue sarcoma

ONCOLOGY

Volumn 21, Issue 4, 2007, Pages 511-514

  Bramwell, Vivien ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MESNA;

CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DESQUAMATION; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FRACTURE; HEMATOLOGIC DISEASE; HUMAN; LEUKOPENIA; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; SOFT TISSUE SARCOMA; TREATMENT INDICATION; TREATMENT PLANNING; WOUND HEALING IMPAIRMENT;

ADULT; CHEMOTHERAPY, ADJUVANT; HUMANS; META-ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; SARCOMA;

EID: 34247382094     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. American Joint Committee on Cancer: Cancer Staging Handbook, 6th ed, p 226. New York, Springer, 2002.
2. Sarcoma Meta-analysis Collaboration: Adjuvant chemotherapy for localized resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Lancet 350:1647-1654, 1997.
3. Frustaci S, Gherlinzoni F, De Paoli A, et al: Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian randomized cooperative trial. J Clin Oncol 19:1238-1247, 2001.
4. Frustaci S, De Paoli A, Bidoli E, et al: Ifosfamide in the adjuvant therapy of soft tissue sarcomas. Oncology 65:80-84, 2003.
5. Gortzak E, Azzarelli A, Buesa J, et al: A randomized phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma. Eur J Cancer 37:1096-1103, 2001.
6. Grobmyer SR, Maki RG, Demetri GD, et al: Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol 15:1667-1672, 2004.
7. Cormier JN, Huang X, Xing Y, et al: Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: Chemotherapy-associated outcomes. J Clin Oncol 22:4567-4574, 2004.
8. Eilber FC, Rosen G, Eckardt J, et al: Treatment-induced pathologic necrosis: A predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol 19:3203-3209, 2001.
9. Eilber FC, Tap W, Nelson SD, et al: Advances in chemotherapy for patients with extremity soft tissue sarcoma. Orthop Clin North Am 37:15-22, 2006.
10. DeLaney TF, Spiro IJ, Suit HD, et al: Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys 56:1117-1127, 2003.
11. Kraybill WG, Harris J, Spiro IJ, et al: Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. J Clin Oncol 24:619-625, 2006.
12. Pisters PWT: Preoperative chemotherapy and split-course radiation therapy for patients with localized soft-tissue sarcomas: Home run, base hit, or strike out? J Clin Oncol 24:549-551, 2006.